(Q28297277)

2

0 references

Koichiro Nozaki

3

0 references

Yu Saida

4

0 references

Tomohiro Tanaka

5

0 references

Satoshi Shoji

6

0 references

Natsue Igarashi

7

0 references

Satoru Miura

8

0 references

Masaaki Okajima

9

0 references

Satoshi Watanabe

10

0 references

Hirohisa Yoshizawa

11

0 references

Ichiei Narita

Cancer Immunology, Immunotherapy

12

0 references

language of work or name

English

0 references

publication date

October 2013

0 references

published in

0 references

volume

62

0 references

issue

10

0 references

page(s)

1619-28

0 references

cites work

Cancer stem cells: distinct entities or dynamically regulated phenotypes?

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

Targeting molecular determinants of tumor chemo-radioresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

CD40 ligand promotes priming of fully potent antitumor CD4(+) T cells in draining lymph nodes in the presence of apoptotic tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

Vaccination with CD133(+) melanoma induces specific Th17 and Th1 cell-mediated antitumor reactivity against parental tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

Functional coherence of the human Y chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

The mutational landscape of head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

SF3B1 and other novel cancer genes in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

The duration of signaling through CD40 directs biological ability of dendritic cells to induce antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

Oncogenic role of DDX3 in breast cancer biogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

Reduced p21(WAF1/CIP1) via alteration of p53-DDX3 pathway is associated with poor relapse-free survival in early-stage human papillomavirus-associated lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

The role of DDX3 in regulating Snail

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

Medulloblastoma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X

Cancer Stem Cells and Radiotherapy: New Insights Into Tumor Radioresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1467-X